Tarja Jonuleit

561 total citations
9 papers, 453 citations indexed

About

Tarja Jonuleit is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Tarja Jonuleit has authored 9 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 5 papers in Genetics and 4 papers in Oncology. Recurrent topics in Tarja Jonuleit's work include Chronic Lymphocytic Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Periodontal Regeneration and Treatments (3 papers). Tarja Jonuleit is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Periodontal Regeneration and Treatments (3 papers). Tarja Jonuleit collaborates with scholars based in Germany and Switzerland. Tarja Jonuleit's co-authors include Horst‐Dieter Lemke, Heiko van der Kuip, Walter E. Aulitzky, O. Kilián, Reinhard Schnettler, Justus Duyster, Michael Hallek, Sabine Wenisch, Ingo Flesch and Anette Jork and has published in prestigious journals such as Blood, Biomaterials and British Journal of Haematology.

In The Last Decade

Tarja Jonuleit

9 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tarja Jonuleit Germany 8 162 158 143 83 77 9 453
Fatemeh Nadali Iran 8 53 0.3× 96 0.6× 104 0.7× 28 0.3× 46 0.6× 29 303
Kerstin Kleinschmidt Germany 11 22 0.1× 75 0.5× 74 0.5× 51 0.6× 128 1.7× 15 341
Miomir Knežević Slovenia 13 16 0.1× 126 0.8× 157 1.1× 52 0.6× 180 2.3× 22 652
Ashish Bakshi India 11 58 0.4× 65 0.4× 69 0.5× 7 0.1× 63 0.8× 34 426
Takatora Takada Japan 5 24 0.1× 36 0.2× 260 1.8× 203 2.4× 83 1.1× 6 685
Sandrine Bekaert Belgium 14 24 0.1× 55 0.3× 91 0.6× 14 0.2× 35 0.5× 19 512
Antoine L. Carre United States 8 11 0.1× 105 0.7× 275 1.9× 35 0.4× 110 1.4× 23 547
Navita Gupta India 7 9 0.1× 212 1.3× 126 0.9× 140 1.7× 115 1.5× 13 446
Caterina Cattani Italy 10 23 0.1× 41 0.3× 65 0.5× 83 1.0× 71 0.9× 16 378
Rong Nie China 12 70 0.4× 32 0.2× 80 0.6× 27 0.3× 149 1.9× 20 450

Countries citing papers authored by Tarja Jonuleit

Since Specialization
Citations

This map shows the geographic impact of Tarja Jonuleit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tarja Jonuleit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tarja Jonuleit more than expected).

Fields of papers citing papers by Tarja Jonuleit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tarja Jonuleit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tarja Jonuleit. The network helps show where Tarja Jonuleit may publish in the future.

Co-authorship network of co-authors of Tarja Jonuleit

This figure shows the co-authorship network connecting the top 25 collaborators of Tarja Jonuleit. A scholar is included among the top collaborators of Tarja Jonuleit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tarja Jonuleit. Tarja Jonuleit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kilián, O., Sabine Wenisch, Srikanth Karnati, et al.. (2008). Observations on the microvasculature of bone defects filled with biodegradable nanoparticulate hydroxyapatite. Biomaterials. 29(24-25). 3429–3437. 23 indexed citations
2.
Kilián, O., Sabine Wenisch, Volker Alt, et al.. (2007). Effects of platelet factors on biodegradation and osteogenesis in metaphyseal defects filled with nanoparticular hydroxyapatite—an experimental study in minipigs. Growth Factors. 25(3). 191–201. 3 indexed citations
3.
Kilián, O., Volker Alt, Christian Heiß, et al.. (2005). New blood vessel formation and expression of VEGF receptors after implantation of platelet growth factor-enriched biodegradable nanocrystalline hydroxyapatite. Growth Factors. 23(2). 125–133. 17 indexed citations
4.
Kilián, O., Ingo Flesch, Sabine Wenisch, et al.. (2004). Effects of platelet growth factors on human mesenchymal stem cells and human endothelial cells in vitro.. PubMed. 9(7). 337–44. 117 indexed citations
5.
Jonuleit, Tarja, et al.. (2001). Monitoring of cell viability and cell growth in a hollow-fiber bioreactor by use of the dye Alamar Blue™. Journal of Immunological Methods. 252(1-2). 131–138. 102 indexed citations
6.
Jonuleit, Tarja, et al.. (2000). The tyrosine kinase inhibitor CGP 57148 (ST1 571) induces apoptosis in BCR-ABL-positive cells by down-regulating BCL-X.. PubMed. 6(5). 1958–68. 69 indexed citations
7.
Jonuleit, Tarja, Heiko van der Kuip, Cornelius Miething, et al.. (2000). Bcr-Abl kinase down-regulates cyclin-dependent kinase inhibitor p27 in human and murine cell lines. Blood. 96(5). 1933–1939. 76 indexed citations
8.
Jonuleit, Tarja, Heiko van der Kuip, Cornelius Miething, et al.. (2000). Bcr-Abl kinase down-regulates cyclin-dependent kinase inhibitor p27 in human and murine cell lines. Blood. 96(5). 1933–1939. 9 indexed citations
9.
Jonuleit, Tarja, Christian Peschel, Renate Schwab, et al.. (1998). Bcr‐Abl kinase promotes cell cycle entry of primary myeloid CML cells in the absence of growth factors. British Journal of Haematology. 100(2). 295–303. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026